Ikarian Capital »

Bioage Labs shares owned by Ikarian Capital

Quarter-by-quarter ownership of Bioage Labs (BIOA) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Bioage Labs

Tip: Access up to 7 years of quarterly data

All positions including Bioage Labs held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioage Labs by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.9M 200k 24.51

More positions owned by Ikarian Capital

Abivax Sa Sponsored Ads (ABVX)
Ionis Pharmaceuticals Call Option (IONS)
Kodiak Sciences (KOD)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Alumis (ALMS)
Praxis Precision Medicines I Com New (PRAX)
Moderna Put Option (MRNA)
Capricor Therapeutics Com New (CAPR)
Vaxcyte (PCVX)
Biosante Pharmaceuticals (ANIP)
Celldex Therapeutics Com New (CLDX)
Tenax Therapeutics Com New (TENX)
Vera Therapeutics Cl A (VERA)
Arcus Biosciences Incorporated (RCUS)
Relmada Therapeutics (RLMD)

View all positions for Ikarian Capital

Top funds holding Bioage Labs

AH Capital Management
BlackRock
Cormorant Asset Management
Sofinnova Ventures
Jupiter Topco
Henderson Group
Octagon Capital Advisors
RA Capital Management
MPM Oncology Impact Management
Vanguard Capital Management
Polar Capital Holdings
Braidwell
Geode Capital Management
State Street Corporation
Sands Capital Ventures

View all funds holding Bioage Labs